Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02775812
Title Cisplatin, Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

laryngeal squamous cell carcinoma

oropharynx cancer

hypopharynx cancer

oral squamous cell carcinoma

head and neck squamous cell carcinoma

Therapies

Cisplatin + Pembrolizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.